January ended on a slow note as Canadian import tariffs and DeepSeek disruption concerns weighed on buyer sentiment ...

All paying members at FNArena are being reminded they can set an email alert specifically for The Overnight Report. Go to ...

Earnings for Kogan.com missed expectations in the second quarter and most analysts do not share Canaccord Genuity's optimism ...

The head & shoulders reversal pattern remains front and centre. It’s also a pattern that could potentially prove to be a ...

The weekend tariff announcement may not be taken well by US equity futures, or risk FX on open, but it certainly validates ...

Manual Processes Hamper Progress: A staggering 41% of teams still rely on manual processes for progress claims, leading to bottlenecks and delays. Compliance Risks: 53% of respondents find meeting ...

Whitehaven Coal's December quarter production was solid and sales surprised to the upside, but on weaker pricing ...

Following Coronado Global Resources' fourth quarter update, analysts focus on operational improvements and upside from the ...

Ironically, Australian Clinical Labs has been identified as at risk for delivering a negative surprise next month, alongside ...

But the regular reference to “adjust” instead of lower policy rates perhaps is an indication that Powell and his team could ...

At the outset of the first update on GenAI in 2025, a brief definition reset is apposite. Such is the scope and scale of ...

UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...